MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 47.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 57,373 shares of the company’s stock after selling 51,248 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Definitive Healthcare were worth $236,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in DH. SG Americas Securities LLC boosted its holdings in Definitive Healthcare by 44.6% in the fourth quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after acquiring an additional 8,387 shares in the last quarter. Rhumbline Advisers boosted its holdings in Definitive Healthcare by 5.2% in the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock worth $334,000 after acquiring an additional 4,034 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Definitive Healthcare by 9.7% in the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock worth $181,000 after acquiring an additional 3,874 shares in the last quarter. New York State Common Retirement Fund boosted its holdings in Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock worth $3,172,000 after acquiring an additional 23,815 shares in the last quarter. Finally, Ieq Capital LLC acquired a new stake in Definitive Healthcare in the fourth quarter worth about $51,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 1.5%

Shares of DH stock opened at $3.32 on Monday. The stock has a 50 day moving average of $2.86 and a 200 day moving average of $3.76. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock has a market cap of $493.49 million, a P/E ratio of -1.07, a P/E/G ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a twelve month low of $2.15 and a twelve month high of $6.27.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The company had revenue of $59.19 million during the quarter, compared to analysts’ expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Definitive Healthcare’s quarterly revenue was down 6.8% on a year-over-year basis. During the same period last year, the business earned $0.08 earnings per share. As a group, sell-side analysts expect that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently commented on DH. BTIG Research downgraded Definitive Healthcare from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. The Goldman Sachs Group lifted their target price on Definitive Healthcare from $3.00 to $3.40 and gave the stock a “neutral” rating in a report on Monday, May 12th. Wall Street Zen downgraded Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Barclays decreased their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a report on Monday, March 3rd. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Definitive Healthcare currently has an average rating of “Hold” and an average price target of $5.10.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.